User:Mark Macbeth/SandboxGiavanna
From Proteopedia
(Difference between revisions)
| Line 8: | Line 8: | ||
<scene name='10/1075216/Practice/2'>Overview Image</scene> | <scene name='10/1075216/Practice/2'>Overview Image</scene> | ||
| - | Where do we begin... | + | Where do we begin... <ref name="Hunt">DOI: 10.1126/scitranslmed.abn1252</ref>. |
It all starts at the ACE2 receptor, but what is that? [https://www.asbmb.org/asbmb-today/science/051620/what-is-the-ace2-receptor Let's investigate!] | It all starts at the ACE2 receptor, but what is that? [https://www.asbmb.org/asbmb-today/science/051620/what-is-the-ace2-receptor Let's investigate!] | ||
| Line 24: | Line 24: | ||
</StructureSection> | </StructureSection> | ||
| - | ==References== | + | ==References== |
| + | |||
===PDB Files=== | ===PDB Files=== | ||
| - | https://www.rcsb.org/structure/7UHB | + | [1]https://www.rcsb.org/structure/7UHB |
==Student Contributors== | ==Student Contributors== | ||
Revision as of 19:47, 18 March 2025
Contents |
SARS CoV-2 Protein Inhibitors (AHB2 and LCB1/LCB3)
| |||||||||||
References
PDB Files
[1]https://www.rcsb.org/structure/7UHB
Student Contributors
- Giavanna Yowell
- Shea Bailey
- Matthew Pereira
